Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD

por Schindler, Suzanne Elizabeth, Fagan, Anne M.
Publicado 2015

CSF sTREM2: marking the tipping point between preclinical AD and dementia?

por Schindler, Suzanne E, Holtzman, David M
Publicado 2016

Association of Acquired and Heritable Factors With Intergenerational Differences in Age at Symptomatic Onset of Alzheimer Disease Between Offspring and Parents With Dementia

por Day, Gregory S., Cruchaga, Carlos, Wingo, Thomas, Schindler, Suzanne E., Coble, Dean, Morris, John C.
Publicado 2019

Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review

por Kumar, Sayantan, Oh, Inez, Schindler, Suzanne, Lai, Albert M, Payne, Philip R O, Gupta, Aditi
Publicado 2021

Extraction of clinical phenotypes for Alzheimer’s disease dementia from clinical notes using natural language processing

por Oh, Inez Y, Schindler, Suzanne E, Ghoshal, Nupur, Lai, Albert M, Payne, Philip R O, Gupta, Aditi
Publicado 2023

GPS driving: a digital biomarker for preclinical Alzheimer disease

por Bayat, Sayeh, Babulal, Ganesh M., Schindler, Suzanne E., Fagan, Anne M., Morris, John C., Mihailidis, Alex, Roe, Catherine M.
Publicado 2021

11 Clinical Manifestations of Neuroaxonal Injury

por Keleman, Audrey A., Wisch, Julie K., Bollinger, Rebecca M., Schindler, Suzanne E., Morris, John C., Ances, Beau M., Stark, Susan L.
Publicado 2023

Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment

por Chen, Charles D., Ponisio, Maria Rosana, Lang, Jordan A., Flores, Shaney, Schindler, Suzanne E., Fagan, Anne M., Morris, John C., Benzinger, Tammie L.S.
Publicado 2023

Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage

por Meeker, Karin L., Butt, Omar H., Gordon, Brian A., Fagan, Anne M., Schindler, Suzanne E., Morris, John C., Benzinger, Tammie L.S., Ances, Beau M.
Publicado 2022

Photo-activatable Cre recombinase regulates gene expression in vivo

por Schindler, Suzanne E., McCall, Jordan G., Yan, Ping, Hyrc, Krzystof L., Li, Mingjie, Tucker, Chandra L., Lee, Jin-Moo, Bruchas, Michael R., Diamond, Marc I.
Publicado 2015

A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease

por Budelier, Melissa M., He, Yingxin, Barthelemy, Nicolas R., Jiang, Hong, Li, Yan, Park, Ethan, Henson, Rachel L., Schindler, Suzanne E., Holtzman, David M., Bateman, Randall J.
Publicado 2022

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease

por Shaw, Leslie M., Arias, Jalayne, Blennow, Kaj, Galasko, Douglas, Molinuevo, Jose Luis, Salloway, Stephen, Schindler, Suzanne, Carrillo, Maria C., Hendrix, James A., Ross, April, Illes, Judit, Ramus, Courtney, Fifer, Sheila
Publicado 2018

Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity

por Rahmani, Farzaneh, Wang, Qing, McKay, Nicole S., Keefe, Sarah, Hantler, Nancy, Hornbeck, Russ, Wang, Yong, Hassenstab, Jason, Schindler, Suzanne, Xiong, Chengjie, Morris, John C., Benzinger, Tammie L.S., Raji, Cyrus A.
Publicado 2022

Falls: a marker of preclinical Alzheimer disease: a cohort study protocol

por Bollinger, Rebecca M, Keleman, Audrey, Thompson, Regina, Westerhaus, Elizabeth, Fagan, Anne M, Benzinger, Tammie LS, Schindler, Suzanne E, Xiong, Chengjie, Balota, David, Morris, John C, Ances, Beau M, Stark, Susan L
Publicado 2021

The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review

por Brand, Abby L., Lawler, Paige E., Bollinger, James G., Li, Yan, Schindler, Suzanne E., Li, Melody, Lopez, Samir, Ovod, Vitaliy, Nakamura, Akinori, Shaw, Leslie M., Zetterberg, Henrik, Hansson, Oskar, Bateman, Randall J.
Publicado 2022

Association Between Socioeconomic Factors, Race, and Use of a Specialty Memory Clinic

por Lewis, Abigail, Gupta, Aditi, Oh, Inez, Schindler, Suzanne E., Ghoshal, Nupur, Abrams, Zachary, Foraker, Randi, Snider, Barbara Joy, Morris, John C., Balls-Berry, Joyce, Gupta, Mahendra, Payne, Philip R.O., Lai, Albert M.
Publicado 2023

Comparison of plasma and CSF biomarkers in predicting cognitive decline

por Aschenbrenner, Andrew J., Li, Yan, Henson, Rachel L., Volluz, Katherine, Hassenstab, Jason, Verghese, Philip, West, Tim, Meyer, Matthew R., Kirmess, Kristopher M., Fagan, Anne M., Xiong, Chengjie, Holtzman, David, Morris, John C., Bateman, Randall J., Schindler, Suzanne E.
Publicado 2022

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease

por Barthélemy, Nicolas R., Saef, Benjamin, Li, Yan, Gordon, Brian A., He, Yingxin, Horie, Kanta, Stomrud, Erik, Salvadó, Gemma, Janelidze, Shorena, Sato, Chihiro, Ovod, Vitaliy, Henson, Rachel L., Fagan, Anne M., Benzinger, Tammie L. S., Xiong, Chengjie, Morris, John C., Hansson, Oskar, Bateman, Randall J., Schindler, Suzanne E.
Publicado 2023

Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer’s disease

por Salvadó, Gemma, Horie, Kanta, Barthélemy, Nicolas R., Vogel, Jacob W., Binette, Alexa Pichet, Chen, Charles D., Aschenbrenner, Andrew J, Gordon, Brian A., Benzinger, Tammie L.S., Holtzman, David M., Morris, John C., Palmqvist, Sebastian, Stomrud, Erik, Janelidze, Shorena, Ossenkoppele, Rik, Schindler, Suzanne E., Bateman, Randall J., Hansson, Oskar
Publicado 2023

Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease

por Wang, Qing, Chen, Gengsheng, Schindler, Suzanne E., Christensen, Jon, McKay, Nicole S., Liu, Jingxia, Wang, Sicheng, Sun, Zhexian, Hassenstab, Jason, Su, Yi, Flores, Shaney, Hornbeck, Russ, Cash, Lisa, Cruchaga, Carlos, Fagan, Anne M., Tu, Zhude, Morris, John C., Mintun, Mark A., Wang, Yong, Benzinger, Tammie L.S.
Publicado 2022